/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/cpg/,/clinical/cckm-tools/content/cpg/hematology-and-coagulation/,/clinical/cckm-tools/content/cpg/hematology-and-coagulation/related/,

/clinical/cckm-tools/content/cpg/hematology-and-coagulation/related/name-97520-en.cckm

201704102

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Clinical Practice Guidelines,Hematology and Coagulation,Related

Appendix B. VTE Risk Assessment - Modified Padua - Adult - Inpatient

Appendix B. VTE Risk Assessment - Modified Padua - Adult - Inpatient - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Clinical Practice Guidelines, Hematology and Coagulation, Related


Appendix C. Modified Padua Risk Assessment Model – Adult – Inpatient – Venous
Thromboembolism (VTE) Prophylaxis – CPG
Risk factors for venous thromboembolism (VTE) in the medical patient
Risk Factor Points
Critically Ill 4
Inflammatory Bowel Disease 4
Active Cancer 3
Previous VTE 3
Reduced Mobility 3
Thrombophilic Condition 3
Recent (< 1month) Trauma/Surgery 2
Age ≥ 70 years 1
Heart or Respiratory Failure 1
Acute Myocardial Infarction or Ischemic Stroke 1
Acute Infection or Rheumatologic Disorder 1
BMI ≥ 30 1
Ongoing Hormonal Treatment 1
VTE prophylaxis recommendations based on risk score
Points Risk Recommendation
< 4 Low VTE Risk VTE prophylaxis not needed
> 4 High VTE Risk and Low Bleed Risk Pharmacologic Prophylaxis
High VTE Risk and High Bleed Risk Mechanical Prophylaxis
Patient
Population
VTE Prophylaxis Regimens
Preferred Option Alternative Option
High VTE Risk Enoxaparin 40 mg SQ every 24 hrs Heparin 5000 units SQ every 8-12 hrs
Renal impairment
(CrCl < 30 mL/min)*
*Not on renal
replacement therapy
Heparin 5000 units SQ every 8-12 hrs Enoxaparin 30 mg SQ every 24 hrs
Extreme obesity
(BMI > 40 kg/M2)
Enoxaparin 40 mg SQ every 12 hrs Heparin 5000 units SQ every 8 hrs
Low body weight
(weight < 50 kg)
Heparin 5000 units SQ every 8-12 hrs Enoxaparin 30 mg SQ every 24 hrs
High Bleeding Risk Intermittent pneumatic compression
devices (IPC)
Graduated compression stockings
(GCS) or Venous foot pumps (VFP)
CPG Contact for Changes:
Name: Philip J Trapskin, PharmD, BCPS
Phone Number: 263-1328
Email Address: ptrapskin@uwhealth.org
Revised: 12/2016
Copyright © 2017 Univ ersity of Wisconsin Hospital s and Clinics Authority
Contact: Lee Vermeulen, CCKM @uwhealth.org Last Revised: 04/2017CCKM@uwhealth.org